Alto Neuroscience

altoneuroscience.com

Alto Neuroscience is a clinical-stage biopharmaceutical company focused on developing precision medicines for neuropsychiatric conditions. Founded by Dr. Amit Etkin in 2019, the company leverages over 15 years of neuroscience research to create targeted treatments for conditions such as major depressive disorder, bipolar depression, and schizophrenia. By utilizing a biology-driven approach, Alto aims to predict clinical responses and match patients with the most effective therapies, thereby disrupting the traditional trial-and-error methods in psychiatry. Their innovative pipeline and commitment to personalized medicine position them as leaders in the evolving landscape of mental health treatment.